Cargando…
Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis
Interferon β-1a is a widely used immunomodulation treatment for multiple sclerosis. Liver function impairment is a common side effect and usually develops in the first 6 months after interferon use. Here, we describe 2 multiple sclerosis patients who developed delayed liver function impairment 5 yea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728605/ https://www.ncbi.nlm.nih.gov/pubmed/23904853 http://dx.doi.org/10.1159/000354042 |